Clinical Trial Update: A Phase 1/2A, Single Dose Study Of PF-04383119 In Japanese Patients With Moderate To Severe Pain From Osteoarthritis Of The Knee [Phase 2]

View source ↗

Summary

Phase 1/2A single-dose study of PF-04383119 in Japanese patients with moderate to severe knee osteoarthritis completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• PF-04383119

Snippet

Sponsor: Pfizer | Conditions: Osteoarthritis, Knee | Phase 2 | Status: COMPLETED | Results posted: 2021-02-21